Biotech Co.*
(Country; Symbol)
Pharma Co.
(Country)
Type/Product Area Terms/Details (Date)
MAY 29 ­ 31
Protea Biosciences Inc.* Laboratoires Mayloy Spindler Drug development partnership giving Protea exclusive marketing rights to recombinant lipase for North America Financial terms were not disclosed (5/29)
JUNE 1 ­ 25
Apthera Inc.*  Kwang Dong Pharmaceutical Co. Ltd. (South Korea) Licensing agreement for NeuVax in South Korea for breast cancer Apthera will receive equity investments as well as milestone and royalty payments (6/4)
Elusys Therapeutics* Lonza Sales AG (Switzerland)  Agreement for the production of Anthim, a therapeutic monoclonal antibody in late-stage development for the treatment of anthrax infection Lonza will provide process development services and manufacturing capacity for that product using Lonza's GS Gene Expression System (6/16)
Notes:

# The information in the chart does not cover agricultural agreements or those between biotech companies. * Private companies are indicated with an asterisk. Unless otherwise noted, stock symbols listed are on the Nasdaq market.